Asthika Goonewardene
Stock Analyst at Truist Securities
(1.29)
# 3,458
Out of 4,876 analysts
98
Total ratings
36.78%
Success rate
-13.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Asthika Goonewardene
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EXEL Exelixis | Reiterates: Buy | $43 → $55 | $43.67 | +25.94% | 9 | Jun 23, 2025 | |
| IGMS IGM Biosciences | Maintains: Hold | $2 → $1 | $1.08 | -7.41% | 9 | Jun 11, 2025 | |
| BNTX BioNTech SE | Reiterates: Buy | $151 → $155 | $106.72 | +45.24% | 2 | Jun 3, 2025 | |
| MRSN Mersana Therapeutics | Maintains: Buy | $9 → $10 | $0.29 | +3,336.43% | 4 | May 16, 2025 | |
| LEGN Legend Biotech | Maintains: Buy | $88 → $71 | $34.63 | +105.02% | 2 | May 14, 2025 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $14 → $10 | $1.18 | +747.46% | 7 | May 14, 2025 | |
| AUTL Autolus Therapeutics | Maintains: Buy | $11 → $10 | $2.32 | +331.97% | 4 | Apr 1, 2025 | |
| GMAB Genmab | Maintains: Buy | $50 → $45 | $20.50 | +119.51% | 14 | Mar 11, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $25 → $15 | $1.69 | +787.57% | 6 | Mar 3, 2025 | |
| CRGX CARGO Therapeutics | Downgrades: Hold | $32 → $7 | $4.19 | +67.06% | 3 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $20.60 | +69.90% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $87 → $136 | $65.35 | +108.11% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $83 → $97 | $110.67 | -12.35% | 1 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $15 | $0.73 | +1,943.60% | 6 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $44 | $7.95 | +453.46% | 1 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $69 → $88 | $52.95 | +66.19% | 2 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.66 | +140.96% | 5 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 | $1.26 | +1,407.94% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $1.25 | +3,112.85% | 4 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $0.63 | +4,215.86% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Hold | $120 | $22.69 | +428.87% | 1 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $100 → $60 | $1.85 | +3,143.24% | 3 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $15 | $0.45 | +3,233.33% | 4 | Aug 23, 2022 |
Exelixis
Jun 23, 2025
Reiterates: Buy
Price Target: $43 → $55
Current: $43.67
Upside: +25.94%
IGM Biosciences
Jun 11, 2025
Maintains: Hold
Price Target: $2 → $1
Current: $1.08
Upside: -7.41%
BioNTech SE
Jun 3, 2025
Reiterates: Buy
Price Target: $151 → $155
Current: $106.72
Upside: +45.24%
Mersana Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $0.29
Upside: +3,336.43%
Legend Biotech
May 14, 2025
Maintains: Buy
Price Target: $88 → $71
Current: $34.63
Upside: +105.02%
Allogene Therapeutics
May 14, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $1.18
Upside: +747.46%
Autolus Therapeutics
Apr 1, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $2.32
Upside: +331.97%
Genmab
Mar 11, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $20.50
Upside: +119.51%
Iovance Biotherapeutics
Mar 3, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $1.69
Upside: +787.57%
CARGO Therapeutics
Jan 30, 2025
Downgrades: Hold
Price Target: $32 → $7
Current: $4.19
Upside: +67.06%
Jan 8, 2025
Initiates: Buy
Price Target: $35
Current: $20.60
Upside: +69.90%
Nov 12, 2024
Maintains: Buy
Price Target: $87 → $136
Current: $65.35
Upside: +108.11%
Nov 8, 2024
Maintains: Hold
Price Target: $83 → $97
Current: $110.67
Upside: -12.35%
Aug 16, 2024
Maintains: Buy
Price Target: $18 → $15
Current: $0.73
Upside: +1,943.60%
Jun 24, 2024
Maintains: Buy
Price Target: $50 → $44
Current: $7.95
Upside: +453.46%
Jun 4, 2024
Maintains: Buy
Price Target: $69 → $88
Current: $52.95
Upside: +66.19%
May 21, 2024
Maintains: Buy
Price Target: $5 → $4
Current: $1.66
Upside: +140.96%
May 16, 2024
Maintains: Buy
Price Target: $19
Current: $1.26
Upside: +1,407.94%
Sep 6, 2023
Reiterates: Buy
Price Target: $40
Current: $1.25
Upside: +3,112.85%
Sep 6, 2023
Reiterates: Buy
Price Target: $27
Current: $0.63
Upside: +4,215.86%
Apr 5, 2023
Reinstates: Hold
Price Target: $120
Current: $22.69
Upside: +428.87%
Aug 23, 2022
Maintains: Hold
Price Target: $100 → $60
Current: $1.85
Upside: +3,143.24%
Aug 23, 2022
Maintains: Buy
Price Target: $19 → $15
Current: $0.45
Upside: +3,233.33%